chrisvoncsefalvay/vaers-outcomes huggingface dataset:
can't see; sick; Clammy; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on 18May2021 as an unknown dose number, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know if the vaccine can make the eyes go blurry. On 22May2021, Saturday, the patient has been sick and clammy and the patient can't see, it was a mess. The patient did not know whether he needs to go to the emergency room or not. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Anxiety, hyperventilation-States "common when getting injections." (1st injection at AACO-DOH on 5/15/2021 EW0183) @14:23     HR=80     SPO2=100%            BP=114/65 @14:32      HR=78      SPO2=100%           BP=112/74 @14:35         Left vaccine clinic
Nurse administered vaccine to child, left room to print immunization record and upon return, child was sobbing. Child and mother left clinic room and went to waiting room. A second nurse entered the waiting room to call another patient back and the child had fainted by the chairs near the front entrance. Nurse and a different patient helped child to chair. Small bruise noted above eyebrow of right eye. Child was diaphoretic and c/o nausea. Ice pack to forehead and back of neck, and orange juice provided. Mother and child left after about 20 minutes of child sitting in chair without difficulty.
He has been very sore and fatigued since 2 hours after he got his vaccine. He also has had a pressure headache since he woke up on 5/15. Sunday 5/16 he woke up at 1am vomiting.
After receiving my first dose of the Pfizer vaccine I got arm pain, headache, armpit pain and fatigue. Eight days later I developed 2 small lymph nodes; one behind my left ear and one on the back of my head.
Client presented for second dose Moderna. Nurse accidentally injected client with syringe that did not have any vaccine in it.  Nurse revaccinated client in left arm without incident.  Nurse talked to client about what happened and assured her that she did not get two vaccines.  Nurse will always double check dosing from now on before administering.
Vaccine stored in refrigerator on 10/26/2021, product expired on 10/13/2021, product administered on 10/29/2021. 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 10/26/2021, product expired on 10/13/2021, product administered on 10/29/2021.) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 10/26/2021, product expired on 10/13/2021, product administered on 10/29/2021.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 10/26/2021, product expired on 10/13/2021, product administered on 10/29/2021.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No adverse events reported.   No temperature excursion of the product was reported.  There was no product complaint associated. Vaccine was refrigerated on 26-Oct-2021.  No treatment medications were reported.   This case was linked to MOD-2022-491837 (Patient Link).
10:40am Fainted, not responsive called. 10:50am life squad, was released to parent-11:15am.
Motor paralysis of the left foot. Could not move at all.: dorsiflex, plantar flex, invert, or evert
My whole upper left arm felt like someone punched me over and over (very sore).  Had a hard time lifting my arm. Upper arm was feverish and a little swollen.  Felt nauseated and had a headache. The soreness in my arm lasted for 4 days. The fever and swelling lasted for 2 days. nausea and headache only lasted for a day. Took Tylenol for the pain and headache.
Patient had COVID-19 illness in January 2021. Had anosmia and loss of taste. Those symptoms fully resolved and she fully recovered. Got her first dose of Pfizer COVID-19 vaccine on 4/1/2021 with no major S/S. Got second dose of Pfizer COVID-19 vaccine on 4/23 /2021 and on that same day noted onset of "rancid" or "greasy, nauseating" smells when smelling foods.
high sensitivity around right eye socket, pain in and behind right ear, pulsing headache, rash/outbreak beneath right eye socket, pain and soreness around injection site
I received Shingrix on Friday, April 15, 2022 and developed chills, fever and constipation on  Saturday and Sunday (4/16 and 17 2022).  Monday, (4/18/2022) had no more fever but was not 100% better.  Tuesday, felt slightly better but had discomfort/abdominal pains (shooting pains, at times) throughout the day.  Wednesday developed diarrhea with shooting pains around abdominal area, right side and pain traveled to lower back and rectum.   Diarrhea lasted for 2 days and constipation started again.  4/23/2022 evening I wasn't feeling too well (flu like symptoms, chills, fatigue, woke up in the middle of the night with heavy nigh sweat) and this morning (4/24/2022) feel really tired/sleepy but was able to pass stool (normal).
Head cold like symptoms including severe head congestion; headache; runny nose; This is a spontaneous report from a non-contactable consumer (patient himself). A 55-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN9581) 1st dose, via an unspecified route of administration, administered in right arm on 03Mar2021 10:00 (age at vaccination: 55 years) as single dose for covid-19 immunization at Health Clinic/Administration facility. The patient's medical history was not reported. Concomitant medications included loratadine (CLARITIN) for unknown indication and from unspecified date. There were no known allergies. On 04Mar2021 10:30, the patient experienced head cold like symptoms including severe head congestion, headache and runny nose. The patient did not receive any treatment for adverse events. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with covid prior to vaccination nor was tested for covid post vaccination. outcome of the events was recovered.  No follow-up attempts are possible. No further information is expected.
my arm started to swell the 2nd day after shot, it swelled from shoulder down to elbow and I couldnt bend it or touch it.  It was hot , red, tender to touch and a rash happened near to shoulder which was irritating.  The skin was tight and edematous.  It lasted more then a week...  it sure was itchy like because of the skin being so tight.   I could not really bend my arm.
fainted approx 1hr p/vax;lethargic for the next 3-3 1/2hr;pt was observed at the MD ofc for 1hr
pt recv vax 27AUG96 & pt devel numerous small pustular vesicles;the vesicles began to fade p/24 hr;pt recovered from sx p/48hr;
After shot was administered on 4-14-15 patient had nausea, dizziness, headache, and large on site reaction.
an unspecified patient had an unspecified allergic reaction to PNEUMOVAX 23; This spontaneous report was received from a pharmacist concerning a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported.   On an unknown date, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) for prophylaxis(dose #, route, lot # and expiration date were unknown).  On an unknown date, the patient had an unspecified allergic reaction to pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23).   At the time of reporting, the outcome of the allergy to vaccine was unknown.     The reporter considered allergy to vaccine to be related to pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23).
Doses administered after 30-day use by date; Date the vial was initially stored in the refrigerator: 17Dec2021/Date of administration of vaccine: 21Feb2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day use by date) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator: 17Dec2021/Date of administration of vaccine: 21Feb2022) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator: 17Dec2021/Date of administration of vaccine: 21Feb2022). On 21-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered after 30-day use by date) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator: 17Dec2021/Date of administration of vaccine: 21Feb2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided. Beyond use date (BUD) of the vaccine was 16-Jan-2022. Date the vial was initially stored in the refrigerator was 17-Dec-2021 and the vial did not undergo any temperature excursions.
Feel like something is stuck in my throat; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date was unknown), via an unspecified route of administration on an unspecified date as a dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced feel like something was stuck in the throat. Stated that, the patient had the COVID shot that were (not clear) on Friday and now the patient think like something was stuck in the throat. Stated that, last night it felt like something was stuck in the patient throat. Stated that, the patient had Pfizer COVID Vaccine. Stated that, the patient was informed about the role of Pfizer Drug Safety. The patient queried that, was this concerned with the shot, right. The patient was provided with the number of Pfizer Medical Information. The outcome of the event was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Hot flashes, flu like symptoms, nauseous, tired, swollen lymph node in armpit of injection arm
ears are ringing continuously, something like tinnitus ringing , it's been going on since 5:00 pm of the day i took the vaccine.
Metallic taste in her mouth; loss of sense of taste; loss of sense of smell; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste in her mouth), AGEUSIA (loss of sense of taste) and ANOSMIA (loss of sense of smell) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included GABAPENTIN, DULOXETINE, FUROSEMIDE, OMEPRAZOLE, IBUPROFEN and ELETRIPTAN for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced DYSGEUSIA (Metallic taste in her mouth), AGEUSIA (loss of sense of taste) and ANOSMIA (loss of sense of smell). On 09-Jan-2021, DYSGEUSIA (Metallic taste in her mouth) had resolved. On 04-Feb-2021, AGEUSIA (loss of sense of taste) and ANOSMIA (loss of sense of smell) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported.    This case was linked to MOD-2021-333537 (Patient Link).; Sender's Comments: This spontaneous case concerns a 51-year-old female patient with no relevant medical history reported who experienced non serous unexpected events of dysgeusia, ageusia and anosmia. The events occurred within 24 hours from the first dose of Spikevax. Rechallenge was unknown since there is no information regarding the second dose and reoccurrence of the events. The benefit-risk relationship of drug is not affected by this report.
This spontaneous case was reported by an other health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (receiving 2 doses of the Moderna COVID19 vaccine and 2 doses of the Pfizer COVID19 vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. aehp235 and jpxcb76) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (receiving 2 doses of the Moderna COVID19 vaccine and 2 doses of the Pfizer COVID19 vaccine). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (receiving 2 doses of the Moderna COVID19 vaccine and 2 doses of the Pfizer COVID19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided.  It was reported that patient received 2 doses of the Moderna COVID-19 vaccine and 2 doses of the Pfizer COVID-19 vaccine.
May be little achy; Arm hurt a lot first time; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (May be little achy) and PAIN IN EXTREMITY (Arm hurt a lot first time) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included AMLODIPINE and ATORVASTATIN for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN (May be little achy) and PAIN IN EXTREMITY (Arm hurt a lot first time). At the time of the report, PAIN (May be little achy) and PAIN IN EXTREMITY (Arm hurt a lot first time) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.    This case was linked to MOD-2021-061122 (Patient Link).
On 03/20/2002 mother states child received vaccinations on 03/11/2002 and noticed no reaction until 03/17/2002 when mother noted a circular area on right arm at the injection site and the area was blotchy red. Mother states child said it was sore and mother felt a knot at the area. On Monday, mother states the area was solid red with no radiation. Mother phoned the doctor and took the pt to the doctor on 03/19/2002 Tuesday. At that time the doctor told mother the area was a result (reaction) to her shot and to just keep an eye on it. I talked with mother today on 03/20/2002 who states the area is smaller and fading.
Patient came in 1 week after receiving both vaccines in the same arm approximately 2 inches apart. She reports a raw rash on the posterior arm and swelling on the entire arm and fingers on the right side. She also reported a similar rash under her breast. Patient also stated that she started sweating profusely after the vaccines were administered. No reports of any pain or redness at the injection site. Patient states that she receives the flu vaccine yearly with no reaction therefore she thinks that this reaction is from the boostrix vaccine
Localized reaction to vaccination with flu and Pneumovax-swelling and pain at injection site.
Child has had fever, sickness, pallor, not sleeping since shots.  Has also had behavioral changes.
This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a adult female patient who received SHINGRIX (batch number 5NY3B, expiry date 13th July 2020) for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb, injection site erythema and injection site pain. On an unknown date, the outcome of the extensive swelling of vaccinated limb, injection site erythema and injection site pain were recovered/resolved. It was unknown if the reporter considered the extensive swelling of vaccinated limb, injection site erythema and injection site pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX in the right arm. The caller was a pharmacist reporting that a patient received a dose SHINGRIX and experienced injection site reactions of swelling, redness and pain that extended down to her elbow and resolved after 4 to 5 days.
Dtap5, IPV and MMR all given that day unsure of if all were put in Left arm. Redness and swelling to left arm. 4-6 y/o shots due. Augmentin and Benadryl were given.
Nauseous; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 28Feb2021 (Batch/Lot number was not reported) as dose number unknown, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the vaccine on 28Feb2021 and have been nauseous from it since the day prior. The patient wanted to know if that is a regular side effect from the vaccine and if that is normal. The outcome of the event was unknown.  No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.
ACUTE DVT, UNSPECIFIED VEIN IATROGENIC PULMONARY EMBOLISM W INFARCTION HYPOXEMIA
Irritable; Limp; Slight fever; This case was reported by a nurse via call center representative and described the occurrence of irritability in a 1-year-old female patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   In February 2019, the patient received the 2nd dose of Pediarix (intramuscular). On an unknown date, less than 9 months after receiving Pediarix, the patient experienced irritability, limping and fever. The patient was treated with antipyretics, nos (Antipyretic). On an unknown date, the outcome of the irritability and limping were recovered/resolved and the outcome of the fever was unknown.   It was unknown if the reporter considered the irritability, limping and fever to be related to Pediarix.  Additional case details were reported as follows: The reporter was the patient's mother. The patient received vaccine in left thigh. The patient was irritable, had a slight fever and was limp at times following the 4th month's vaccine administration. The reporter stated patient was limp but once given some fever reducer she perked up. The reporter did not consent to follow up.
Sore arm 3 days. Fever and exhaustion 2nd day extremely cold. Felt similar to when I had Covid but worse. 3rd day still tired but other symptoms gone.
This spontaneous report was received from a other health professional refers to a 61 year old female patient. On 15-AUG-2014 the patient was vaccinated with ZOSTAVAX lot # J004311; expiry: 12-JUL-2014, 0.65 ml (millilitres), subcutaneous in the left arm. No concomitant medications were reported. On 15-AUG-2014, the patient was administered with expired vaccine of ZOSTAVAX. The outcome of administered with expired vaccine is unknown. No adverse effects reported. There was no product quality complaint (PQC) involved. Additional information is not expected.
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    It was unknown if patient received any other vaccines 4 weeks prior to COVID-19 vaccine administration.  190 patients (9 different lot numbers) received a vaccine past the beyond used by date.  No concomitant medication reported. No treatment medication reported.  This case pertains to the 99th of the total 190 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335: case